[back to previous text]

Dr. Pugh: The problem with the amendment is that it does not go far enough. The line that we will take both on Report and in Committee is that cigarette vending machines are out of order and that we support the British Heart Foundation’s attempt to eradicate them totally. Let me briefly explain why.
Cigarette vending machines are anachronistic and date back to the times when shops closed at 6 o’clock, and desperate smokers looking for a cigarette could only get them from a vending machine. On Sundays, too, it was hard to get a supply of cigarettes. As a result, the machines came into being.
Mike Penning: I apologise for taking up the hon. Gentleman’s time, but what a load of tosh. I have never heard so much rubbish in my entire life. If someone goes into any pub in this country, they are highly unlikely to be able to purchase cigarettes in any other way. To say that it is something to do with the machines being used late on a Saturday night and that they are an old-fashioned anachronism is completely wrong. Whether we like it or not, it is the only way in which cigarettes can be purchased in most premises these days. That is because of the stock issue, to which I alluded earlier.
Dr. Pugh: Clearly, it would be a disincentive for people to smoke if they had to leave the premises to get cigarettes. On a personal note, my son recently gave up smoking. The most difficult situation for smokers when they have given up is after they have had a few pints and they are relaxed, so if we are looking at a measure that will prevent people from going back to smoking, banning the machines is probably the best one.
The machines are not just anachronistic, but slightly odd—after all, we do not have alcohol-dispensing machines with controls on them. There must be some reason why the Europeans, having explored the logic, have gone down the route of largely abolishing them. We were talking about flaky evidence and evidence pointing both ways, but the evidence here is entirely clear cut. The machines represent a small section of total cigarette sales, but one in six child smokers use them. There is no doubt that the evidence shows that children disproportionately use them. The evidence also shows that attempts to get round that by having token systems or monitoring and other such measures simply do not work.
We have talked about displays before. One of the great arguments for not having displays is that it will stop people from going back to smoking and it will stop children from smoking. Vending machines encourage people to go back to smoking because, in the pub, they can be found very easily. They are clearly used by children and will continue to be used no matter what controls are brought in, because children, when they want to smoke and get round legislation, are very canny at doing so.
Gillian Merron: I appreciate the points that have been made, but I will answer them under the next set of amendments or on clause stand part, should debate on that.
The direct effect of amendment 91 is that it would compel the Governments of England and Wales to regulate vending machines. I can confirm that it is the intention of this Government to introduce new regulations on vending machines to ensure that under-age sales are prevented. The Department is already working with key stakeholders in the vending machine business and enforcement agencies to develop draft regulations that will allow practical, effective and cost-effective solutions to the problem. We will have the draft regulations ready for consultation as soon as we can, and we are committed to commencing them from October 2011.
I confirm that Welsh Ministers will consult with relevant health and business organisations and with members of the public in Wales before determining how detailed regulation on the sale of tobacco products from vending machines will be taken forward under their jurisdiction. The effect of the tobacco provisions in the Bill is to devolve powers on tobacco displays and vending machines to the relevant national authorities. We note that the amendment will cut across that intention, thereby imposing a legislative imperative on the Welsh Assembly Government. Under the principle of devolution, we believe it is appropriate to leave it to them to decide how and when to use their powers. I therefore hope that the hon. Member for Hemel Hempstead will not pursue the amendment.
Mike Penning: Reading through the other amendments, this is almost a stand part debate. I appreciate your leniency, Mr. Key, in allowing it to happen.
Having listened to the Minister, I think that my probing amendment has done its job. We have heard more from the Minister in the past five minutes than is written anywhere on the face of the Bill about the Government’s proposals. On the next set of amendments I shall tease out a fraction more, but I beg to ask leave to withdraw the amendment.
Amendment, by leave, withdrawn.
The Chairman: I am of the opinion that we have explored the matter fully and it will not be necessary to have a clause stand part debate.
Clause 22 ordered to stand part of the Bill.
Clauses 23 and 24 ordered to stand part of the Bill.
Schedule 4 agreed to.

Clause 25

Pharmaceutical needs assessments
Mr. Stephen O'Brien: I beg to move amendment 34, in clause 25, page 28, line 6, after ‘area’, insert
‘including an assessment of local needs for the services of dispensing doctors.’.
The Chairman: With this it will be convenient to take the following: amendment 35, in clause 25, page 28, line 9, at end insert—
‘(za) placing a duty on primary care trusts to consult patients, Local Involvement Networks and members of the public on local needs for pharmaceutical services.’.
Amendment 33, in clause 25, page 28, line 16, at end insert—
‘(e) requiring the Secretary of State to implement pilot schemes for primary care trusts in carrying out pharmaceutical needs assessments before they are rolled out nationally; and for those pilot schemes to be evaluated 12 months after they commence.’.
Mr. O'Brien: Amendment 34 would place a duty on PCTs to take into account the services of dispensing doctors in their assessment of local pharmaceutical needs. We have now moved on to the clause dealing with pharmaceutical services in England and the needs assessments as they are proposed in the Bill. Amendment 35 would ensure that patients are consulted as part of each pharmaceutical needs assessment. Amendment 33 proposes pilot schemes for PNAs.
Amendment 35 would ensure that each PNA includes patient consultation. The principal purpose of the PNA should be to enhance local pharmaceutical services for patients and ensure that the area covered by the PCT is adequately provided for. We agree with the concept of giving PCTs local control over the provision of pharmaceutical services, but we want to make sure that patient choice is enhanced rather than overruled. At present, the Bill does not make any provision for patients to express their views in the assessment—an odd omission, given that patients are the users of the services provided under a PNA. Will the Minister confirm that the regulations will make provision for patient consultation? My amendment would ensure that PCTs include the results of such a consultation in their published PNAs, so that patients can be assured that their views were taken into account. If a PCT goes against the wishes of patients, the general public will be able to see that that is the case by examining the consultation.
Accounting for the views of patients in PNAs is particularly relevant in rural areas, where pharmaceutical services are less abundant. Many patients have to travel long distances to access services, and consequently people make extensive use of dispensing doctors, so that they can combine their visit to the doctor and the collection of their medicines. There is nothing in the Bill to prevent PCTs from cutting those services. As my noble Friend Lord Howe argued in the other place, many of the pharmacy community are concerned that the current PNAs are
“disproportionately focused on cost-effectiveness and not enough on health need”.
That means that these services face a real risk of being axed.
I have already fought a real battle on the subject in my constituency—with some success, I am glad to say. It revolved to some extent around the definition of what is rural and what is associated with an urban or suburban environment. Having said that, if any sort of assessment militates against the extension of dispensing doctors, it would be a very real threat to the rural community. Amendment 34 would ensure that the services of dispensing doctors are taken into consideration in PNAs, along with the views of patients, the majority of whom want to keep the services of dispensing practices.
4.45 pm
On the management of dispensing practices, I am sure that the Minister will come back to me with the same assurance that his colleague the Minister of State, Department of Health, the hon. Member for Corby (Phil Hope), gave in December 2008: that the Government do not intend to make any changes to the current arrangements for the dispensing of medicines to patients by GPs. However, I am slightly less inclined to trust the good will of the Government, given that they made that pledge last year before the publication of the Bill but they have clearly left a gaping hole in the legislation on that matter.
It is of more concern that the Government appear to be ignoring the wishes of NHS patients. Some 62,675 patients registered with a dispensing practice responded directly to the pharmacy White Paper consultation to express their support for no change to GP dispensing. However, the Bill makes no provision for PCTs to consider the services offered by dispensing doctors in their needs assessment. What firm and evidence-based assurance can the Minister give that patients who are registered with dispensing practices will not see those services axed by their PCTs?
It is fair to say that many of the satellite surgeries of doctors’ practices are, particularly in rural areas, cross-funded because they have a dispensing practice. Far from doctors seeking to increase the drawings from their own practice, it is cross-subsidy that enables them to have a satellite service to reach out into the more remote rural areas. The dispensing practice enables that.
Amendment 33 proposes pilot schemes, which would enable the PCT and the Government to investigate whether the local assessment of pharmaceutical needs results in adequate provision of services. It would also give PCTs a chance to experiment with the format and content of the PNA to ensure that any complications are addressed and that the assessment is wide ranging enough to be taken into account when a provider applies to the pharmaceutical list.
The Government’s own White Paper on pharmacy concedes that
“there is considerable variation in the scope, depth and breadth of PNAs”.
It also states:
“The structure of and data requirements for PCT PNAs require further review and strengthening to ensure they are an effective and robust commissioning tool which supports PCT decisions.”
Although I realise that the Government see the Bill as the occasion for review and strengthening, a pilot programme would be the opportune moment to examine and trial the content of PNAs in a practical setting. PCTs would also be able to adapt to producing more rigorous PNAs. Examples of best practice could be disseminated before the scheme is rolled out across the country.
Anne Galbraith’s 2008 review of NHS pharmaceutical contractual arrangements, which was published alongside the White Paper, made the point that
“Pharmaceutical Needs Assessments...should have a consistent structure across all PCTs and have national comparability in breadth and depth.”
One potentially negative consequence of localisation is that there will no longer be a framework for ensuring that PCTs maintain that comparability across the country. Of course, the regulations will seek to qualify the information contained in the PNA and the manner in which it is conducted. However, we have not had sight of those regulations, so we do not know the extent to which they guide PCTs on the form and content of a PNA. If the Government were to run a pilot scheme and report back to Parliament with the results in 12 months’ time, they would have a solid evidence base from which to move forward. In addition, PCTs would have increased knowledge of how best to utilise the PNA to gain the best possible access to pharmaceutical services for their patients.
Dr. Pugh: I have to apologise for the fact that my hon. Friend the Member for Romsey is not here, because she is the expert on this subject and would have a great deal more to say than I have. I have no problem with the general tenor of what the Government are endeavouring to do. Public authorities have always had to strike a balance so that naked commercial interests do not dominate the pharmaceutical world. The needs of the community are paramount, and there has always been a need to structure the market publicly in some way. Anybody who has been an elected councillor or any sort of elected representative will have been lobbied at some point by a pharmacy or a dispensing physician about their position, their share of the market and the placing of other facilities close to them.
I agree with the hon. Member for Eddisbury that whatever is done needs to be properly and thoroughly evidence-based, and if it is not evidence-based everywhere, it will not be well done. It cannot be lobby-based, because there are plenty of powerful interests in the pharmaceutical world and many prosperous commercial practices that will weigh in heavily to get their way if left to their own devices. I therefore warm to the amendments because they would preserve the rights of dispensing practices, particularly in rural areas, and they make clear that the market must serve patients rather than simply appear by accident and as a result of commercial happenstance.
Mr. Mike O'Brien: I, too, represent a rural area where dispensing doctor’s practices exist and operate, and I very much understand the concerns of some GP practices that, in order to maintain satellite practices, they sometimes have to have funding from a dispensary. Indeed, a dispensary provides a facility for local people in such communities. At the same time, there is always a concern where doctors both prescribe and dispense, and it is right to exercise caution when dealing with that. Dispensing clearly offers an income, so we need to be careful that we deal with the issue appropriately. I believe that, in most cases, doctors act with a professional integrity on which we can broadly rely. However, we need to be continually aware that individuals may not always act with such integrity; the appropriate disciplinary procedures for doctors will deal with that.
On Second Reading, the hon. Member for Eddisbury said:
“The move to pharmaceutical needs assessments is welcome.”—[Official Report, 8 June 2009; Vol. 493, c. 612.]
I am glad that he said that. I make it clear that, as we announced before Christmas, we will not change the current system for determining whether doctors can dispense to their patients. On primary care trusts in rural areas where most dispensing by doctors takes place, it is important that such services are considered within their overall assessments of needs.
It has been asked whether services by dispensing doctors could be at risk from bad PCT decisions on new applications. The current regulations already contain provisions to take into account any prejudice to existing service providers in rural areas from new applicants, and I stress that that safeguard will continue in the new regulatory system.
The clause requires PCTs to undertake and publish their assessments of pharmaceutical needs in accordance with regulations. The Department will work closely with interested parties, including NHS and contractor representatives, as well as doctors, on drafting the requirements. I announced last Thursday the formation of an advisory group for that very purpose. However, not all PCTs need to resort to the services of dispensing doctors. It is important that such services are available for the patients who use them in rural areas, but they have little relevance, if any, in non-rural PCTs across the country. We need to get the issue right, and I hope that my reassurances have been satisfactory and that the amendment will be withdrawn.
 
Previous Contents Continue
House of Commons 
home page Parliament home page House of 
Lords home page search page enquiries ordering index

©Parliamentary copyright 2009
Prepared 25 June 2009